U.S. RESEARCH ROUNDUP-Accenture, LyondellBasell Industries, Reata Pharmaceuticals

Sio Gene Therapies

20/12/2019 07:34

Dec 20 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Accenture, LyondellBasell Industries and Reata
Pharmaceuticals, on Friday. 
    
  HIGHLIGHTS
     * Accenture Plc  ACN.N : RBC raises target price to $220 from $196
     * LyondellBasell Industries NV  LYB.N : RBC cuts to sector perform from outperform
     * Reata Pharmaceuticals Inc  RETA.O : Jefferies raises target price to $308 from $254
  
Following is a summary of research actions on U.S. companies reported by Reuters on Friday.
Stock entries are in alphabetical order.

     * AAR Corp  AIR.N : Canaccord Genuity raises target price to $55 from $52
     * Accenture Plc  ACN.N : RBC raises target price to $220 from $196
     * Akorn Inc  AKRX.O : Jefferies cuts target price to $2 from $5
     * Allakos Inc  ALLK.O : Jefferies raises target price to $132 from $96
     * Amgen Inc  AMGN.O : Jefferies raises target price to $285 from $235
     * Anaptysbio Inc  ANAB.O : Jefferies raises target price to $16 from $12
     * Arrowhead Pharmaceuticals Inc  ARWR.O : Jefferies raises target price to $77 from $66
     * Arthur J Gallagher & Co  AJG.N : RBC raises target price to $93 from $91
     * Assembly Biosciences Inc  ASMB.O : Jefferies raises target price to $30 from $25
     * Atara Biotherapeutics Inc  ATRA.O : Jefferies raises target price to $14 from $13
     * Axovant Gene Therapies Ltd  AXGT.O : Jefferies cuts target price to $13 from $16
     * Bausch Health Companies Inc  BHC.N : Jefferies raises target price to $35 from $32
     * Baxter International Inc  BAX.N : JP Morgan raises target price to $94 from $89
     * Becton Dickinson and Co  BDX.N : JP Morgan raises target price to $300 from $285
     * Biogen Inc  BIIB.O : Jefferies raises target price to $325 from $310
     * Bridgebio pharma Inc  BBIO.O : Jefferies raises target price to $43 from $38
     * Calamp Corp  CAMP.O : Canaccord Genuity cuts target price to $17 from $24
     * Calamp Corp  CAMP.O : JP Morgan cuts target price to $14 from $15
     * Cognizant Technology Solutions Corp  CTSH.O : RBC raises target price to $72 from $70
     * Constellation Pharmaceuticals Inc  CNST.O : Jefferies raises target price to $55 from $40
     * Deciphera Pharmaceuticals Inc  DCPH.O : Jefferies raises target price to $77 from $53
     * Dexcom Inc  DXCM.O : JP Morgan raises target price to $255 from $215
     * Dorian LPG  LPG.N : Evercore ISI initiates with outperform rating and price target of $19
     * F5 Networks Inc  FFIV.O : Jefferies cuts target price to $135 from $150
     * Fate Therapeutics Inc  FATE.O : Jefferies raises target price to $26 from $22
     * General Mills Inc  GIS.N : Evercore ISI raises target price to $56 from $54
     * General Mills Inc  GIS.N : Evercore ISI raises target price to $56 from $54
     * Gilead Sciences Inc  GILD.O : Jefferies cuts target price to $80 from $95
     * Glaukos Corp  GKOS.N : JP Morgan cuts target price to $65 from $90
     * IGM Biosciences Inc  IGMS.O : Jefferies raises target price to $42 from $25
     * Inogen Inc  INGN.O : JP Morgan raises target price to $60 from $47.50
     * Insulet Corp  PODD.O : JP Morgan raises target price to $200 from $170
     * Intercept Pharmaceuticals Inc  ICPT.O : Jefferies raises target price to $145 from $125
     * La Jolla Pharmaceutical Co  LJPC.O : Jefferies raises target price to $3.5 from $3
     * Live Nation Entertainment Inc  LYV.N : Evercore ISI raises target price to $82 from $73
     * LyondellBasell Industries NV  LYB.N : RBC cuts to sector perform from outperform
     * LyondellBasell Industries NV  LYB.N : RBC cuts target price to $95 from $102
     * Medtronic Plc  MDT.N : JP Morgan raises target price to $128 from $122
     * Mirati Therapeutics Inc  MRTX.O : Jefferies raises target price to $133 from $117
     * Nantkwest Inc  NK.O : Jefferies raises target price to $4 from $1.25
     * Neurocrine Biosciences Inc  NBIX.O : Jefferies raises target price to $127 from $117
     * Nevro Corp  NVRO.N : JP Morgan raises target price to $96 from $80
     * Nextgen Healthcare Inc  NXGN.O : Jefferies cuts target price to $14 from $17
     * Nike Inc  NKE.N : JP Morgan raises target price to $110 from $109
     * Nike Inc  NKE.N : Susquehanna raises target price to $115 from $106
     * Nvent Electric Plc  NVT.N : RBC raises target price to $27 from $25
     * Phillips 66 Partners LP  PSXP.N : RBC raises target price to $65 from $62
     * Prothena Corporation Plc  PRTA.O : Jefferies raises target price to $14 from $10
     * Reata Pharmaceuticals Inc  RETA.O : Jefferies raises target price to $308 from $254
     * Rubius Therapeutics Inc  RUBY.O : Jefferies cuts target price to $25 from $30
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))